ATLAS Simulation and ATLAS Surgeon enable neurosurgeons to rehearse complex brain procedures using ultra-realistic, AI-enhanced virtual twins tailored to each patientATLAS Simulation and ATLAS Surgeon enable neurosurgeons to rehearse complex brain procedures using ultra-realistic, AI-enhanced virtual twins tailored to each patient

ATLAS Meditech Introduces Patient-Specific Virtual Brain Twins to Enhance Precision and Safety in Brain Surgery

4 min read

ATLAS Simulation and ATLAS Surgeon enable neurosurgeons to rehearse complex brain procedures using ultra-realistic, AI-enhanced virtual twins tailored to each patient’s anatomy.

SAN FRANCISCO, Feb. 2, 2026 /PRNewswire/ — ATLAS Meditech, a leader in intelligent care augmentation, creator of AtlasGPT, proven as the most reliable decision support platform for 35 specialties of medicine, today highlights the powerful capabilities of its ATLAS Simulation platform and the enterprise-level ATLAS Surgeon solution. These tools deliver ultra-realistic, AI-enhanced virtual twin environments designed to transform brain surgery by patient-specific surgical rehearsal in neurosurgery. This technology will also usher a new era in synthetic and generative brain structure for more precise surgery.

Pioneered and clinically applied at the ATLAS Institute of Brain and Spine in Los Angeles, led by world-renowned neurosurgeon Dr. Aaron Cohen-Gadol, this groundbreaking technology is already elevating patient outcomes in one of the most advanced neurosurgical practices in the world. The ATLAS Institute of Brain and Spine specializes in complex brain and spine conditions, leveraging these virtual twin innovations alongside minimally invasive techniques to treat high-risk tumors, cerebrovascular diseases, and spine disorders with unparalleled precision and safety.

Key highlights from the platform include:

  • Safest and most Effective Surgical Trajectory for High-Risk Brain Tumors — Advanced algorithms deliver the safest and most efficient paths to brain tumors located in previously unreachable regions via surgery.
  • Minimally Invasive Surgery — Surgeons can meticulously and confidently plan incisions, bony openings, and within an ultra-realistic virtual twin environment for optimal success via minimally invasive routes not possible before while ensuring adequate exposure for effective surgery.
  • Operating Room Teamwork — An ultra-realistic virtual OR environment allows teams to plan and execute efficiently, providing a seamless workflow in the operating room, shortening the time the patient is under anesthesia.

Additional standout features and metrics include highlighting 101 high-risk ‘Hazard Zones’ in the brain for enhanced safety and utilizing a 75 million polygon 3D model—the most accurate and detailed virtual twin of the human brain ever created.

“ATLAS Simulation and ATLAS Surgeon represent the pinnacle of neurosurgical preparation,” said Dr. Aaron Cohen-Gadol, a neurosurgeon and Founder of ATLAS Meditech. “By combining ultra-realistic digital twins and advanced AI algorithms, we empower surgeons to plan with unprecedented confidence, reduce risks, and improve outcomes for complex brain procedures.”

These platforms build on ATLAS Meditech’s commitment to innovation and AI-driven decision support. The ATLAS Institute of Brain and Spine stands at the forefront of translating this technology into real-world excellence, delivering world-class neurosurgical care in Los Angeles for patients with complex brain tumors, aneurysms, AVMs, cavernous malformations, and spinal disorders who come from all over the world for best care.

Flexible access options include free trials and subscription plans, with enterprise solutions tailored for institutions. Neurosurgeons and healthcare teams can explore the platforms at https://sim.atlasmeditech.com, view plans and pricing, start a free trial, or request an ATLAS Surgeon demo.

To learn more about how these innovations are applied in clinical practice or to seek consultation for complex brain and spine conditions, visit the ATLAS Institute of Brain and Spine at www.atlasneurosurgeryinstitute.com.

About ATLAS Meditech Atlas Meditech pioneers next-generation medical and surgical intelligence, including AI superintelligent assistants, simulation platforms, and tools that augment clinical decisions across neurosurgery and beyond. Rooted in collaboration with the Neurosurgical Atlas and focused on evidence-based innovation, the company advances precision medicine to elevate surgical excellence worldwide.

Led by Dr. Aaron Cohen-Gadol, the ATLAS Institute of Brain and Spine in Los Angeles provides world-renowned, minimally invasive neurosurgical care for complex brain and spine disorders. As a pioneer in integrating advanced AI and virtual twin technologies, the Institute delivers personalized, high-precision treatments to optimize safety, preserve neurological function, and accelerate recovery. For more information, visit www.atlasneurosurgeryinstitute.com.

Media Contact
AtlasMeditech@nsatlas.com | +1 (317) 362-8760

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/atlas-meditech-introduces-patient-specific-virtual-brain-twins-to-enhance-precision-and-safety-in-brain-surgery-302676561.html

SOURCE Atlas Institute of Brain & Spine

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
XRP Ledger Unlocks Permissioned Domains With 91% Validator Backing

XRP Ledger Unlocks Permissioned Domains With 91% Validator Backing

XRP Ledger activated XLS-80 after 91% validator approval, enabling permissioned domains for credential-gated use on the public XRPL. The XRP Ledger has activated
Share
LiveBitcoinNews2026/02/06 13:00
TrendX Taps Trusta AI to Develop Safer and Smarter Web3 Network

TrendX Taps Trusta AI to Develop Safer and Smarter Web3 Network

The purpose of collaboration is to advance the Web3 landscape by combining the decentralized infrastructure of TrendX with AI-led capabilities of Trusta AI.
Share
Blockchainreporter2025/09/18 01:07